No Authorization For OTC Monograph Reform And User Fees, But Webinar Goes On

FDA’s Aug. 23 webinar will update industry stakeholders on progress to modernize its OTC monograph program, but without user fee legislation, new performance goals will not take effect; stakeholders hold out hope a standalone OTC user fee bill could still progress in Congress.

GoldKeyInPuzzle_1200x675

More from Legislation

More from Policy & Regulation